文献速递脑血管病神经重症与神经感染

血管内治疗后血压变化幅度与结局:BP-TARGET试验的启示

Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial.
PubMed 文献 · Stroke · 2022-02-03

该研究为BP-TARGET多中心试验的事后分析,纳入267例成功再灌注患者,评估术后不同时间间期收缩压变化(ΔSBP)与影像学和临床结局的关联。结果显示ΔSBP15-60M和ΔSBP6-24H与较低的不良功能结局 odds 相关,ΔSBP15-60M与任何脑实质出血 odds 较低相关,ΔSBP与死亡率或神经功能恶化无关。

要点

  • 术后15-60分钟和6-24小时收缩压下降幅度越大,90天不良功能结局 odds 越低。
  • 术后15-60分钟收缩压下降幅度越大,任何脑实质出血 odds 越低。
  • 收缩压变化幅度与死亡率或神经功能恶化无显著关联。

核心结论

  • 成功再灌注后,ΔSBP与不良结局呈线性关系,收缩压较基线下降越少,不良结局风险越高。

研究设计与样本

  • BP-TARGET多中心试验的事后分析,共纳入267例患者(强化治疗组130例)。
  • ΔSBP定义为手术结束时收缩压减去术后不同时间间期(15-60分钟、1-6小时、6-24小时)的平均收缩压。
  • 主要结局为90天改良Rankin量表评分3-6分的不良功能结局。

主要发现

  • 与良好结局患者相比,不良结局患者在所有时间间期的ΔSBP均较低(收缩压下降较少)。
  • 调整包括基线收缩压在内的潜在混杂因素后,ΔSBP15-60M与较低的不良结局 odds 相关(每降低5 mm Hg收缩压,调整OR 0.89 [95% CI, 0.81-0.99])。
  • ΔSBP6-24H与较低的不良结局 odds 相关(每降低5 mm Hg收缩压,调整OR 0.82 [95% CI, 0.73-0.92])。
  • 脑实质出血患者在所有时间间期的ΔSBP均较低;ΔSBP15-60M与任何脑实质出血 odds 较低相关(每降低5 mm Hg收缩压,调整OR 0.91 [95% CI, 0.83-0.99])。
  • ΔSBP与死亡率或神经功能恶化在任何时间间期均无关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To assess the association between systolic blood pressure change (ΔSBP) at different time intervals after successful reperfusion with radiographic and clinical outcomes. METHODS: This is a post hoc analysis of the BP-TARGET multicenter trial (Blood Pressure Target in Acute Stroke to Reduce Hemorrhage After Endovascular Therapy). ΔSBP was defined as end of procedure SBP minus mean SBP at different time intervals (15-60 minutes, 1-6 hours, and 6-24 hours postprocedure). The primary outcome was the poor functional outcome (90-day modified Rankin Scale score 3-6). RESULTS: We included a total of 267 patients (130 in the intensive treatment group). Compared with patients with favorable outcome, patients with poor outcome had lower ΔSBP (less SBP reduction) at all times intervals. After adjusting for potential confounders including baseline SBP, both ΔSBP15-60M and ΔSBP6-24H were associated with lower odds of poor outcome (adjusted odds ratio per 5 mm Hg SBP reduction, 0.89 [95% CI, 0.81-0.99], and adjusted odds ratio 0.82 [95% CI, 0.73-0.92], respectively). Concerning safety outcomes, patients with intraparenchymal hemorrhage had lower ΔSBP at all time intervals. ΔSBP15-60M was associated with lower odds of any intraparenchymal hemorrhage (adjusted odds ratio per 5 mm Hg SBP reduction 0.91 [95% CI, 0.83-0.99]). Conversely, ΔSBP was not associated with mortality or neurological deterioration at any time interval. CONCLUSIONS: After successful reperfusion, ΔSBP had a linear relationship with poor outcome and the risk of poor outcome was higher with less reduction from the baseline SBP. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03160677.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Anadani M, Maïer B, Escalard S, et al. Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial. Stroke. 2022. PMID: 35109685. doi:10.1161/STROKEAHA.121.036701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。